Purchases and Sales Made in Q1 2022 in Cin Cor Pharma, Inc. (CINC)
This table provides information about the institutional ownership of Cin Cor Pharma, Inc. (CINC) during Q1 2022. The information is specifically focused on institutions that hold shares of CinCor Pharma, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 12, 2022
Q1 2022
|
Metropolitan Life Insurance CO
New York, NY |
BUY
|
- |
948New |
$13.4K - $27K
|
948
$0
|
|
Jun 20, 2023
Q1 2022
|
Metropolitan Life Insurance CO
New York, NY |
BUY
|
- |
948New |
$13.4K - $27K
|
948
$0
|
|
May 13, 2022
Q1 2022
|
Ameritas Investment Partners, Inc.
Lincoln, NE |
BUY
|
- |
900New |
$12.7K - $25.6K
|
900
$0
|
|
May 12, 2022
Q1 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
447New |
$6.32K - $12.7K
|
447
$0
|
|
May 09, 2022
Q1 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Mar 30, 2023
Q1 2022
|
Metropolitan Life Insurance CO
New York, NY |
SELL
|
- |
-694- 42.27% |
$9.81K - $19.8K
|
948
$0
|
|
Mar 22, 2023
Q1 2022
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-3.37K- 29.39% |
$47.6K - $95.9K
|
8.09K
$0
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-20K- 86.82% |
$283K - $571K
|
3.04K
$0
|